Imara Inc (IMRA) |
|
9.97 -2.34 (-19.01%)
|
03-07 02:50 |
|
Open: |
10.11 |
Pre. Close: |
12.31 |
|
High:
|
10.75 |
Low:
|
8.495 |
|
Volume:
|
557,889 |
Market Cap:
|
174M |
|
|
|
|
Imara, Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. It develops IMR-687, which is an oral, once-a-day therapeutic for the treatment of sickle cell disease and b-thalassemia. The company was founded in 2016 and is headquartered in Boston, Massachusetts. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
10.766 - 10.841 |
10.841 - 10.899 |
|
Low:
|
8.331 - 8.413 |
8.413 - 8.477 |
|
Close:
|
9.837 - 9.967 |
9.967 - 10.067 |
|
Technical analysis |
as of: 2021-03-05 5:09:29 PM |
|
Overall:
|
  |
| Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 14.60 One year: 17.50 |
| Support: |
Support1: 8.49 Support2: 7.07 |
| Resistance: |
Resistance1: 12.50 Resistance2: 14.98 |
| Pivot: |
12.97 |
| Moving Average: |
MA(5): 12.54 MA(20): 13.32
MA(100): 18.07 MA(250): |
| MACD: |
MACD(12,26): -0.87 Signal(9): -0.79 |
| Stochastic oscillator: |
%K(14,3): 27.32 %D(3): 38.30 |
| RSI: |
RSI(14): 27.55 |
| 52-week: |
High: 62.71 Low: 8.49 Change(%): -33.5 |
| Average Vol(K): |
3-Month: 13921 10-Days: 13093 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.IMRA has closed below the lower band by 26.3%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 39.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Fri, 05 Mar 2021
Imara, Inc. (IMRA) CEO Rahul Ballal on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha
Fri, 05 Mar 2021
54 Stocks Moving In Friday's Mid-Day Session - Benzinga
Fri, 05 Mar 2021
Form 8-K IMARA Inc. For: Mar 05 - StreetInsider.com
Fri, 05 Mar 2021
Imara Reports Full Year 2020 Financial Results and Business Highlights - GlobeNewswire
Fri, 05 Mar 2021
Imara Inc to Host Earnings Call - Yahoo Finance
Fri, 26 Feb 2021
Imara to Webcast Conference Call of Full Year 2020 Financial Results and Business Highlights - GlobeNewswire
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
17 |
| Shares Float (M) |
6 |
|
% Held by Insiders
|
22.52 |
|
% Held by Institutions
|
64.60 |
|
Shares Short (K)
|
622 |
|
Shares Short P. Month (K)
|
473 |
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
|
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-2.156 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-37 |
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
|
|
Price to Cash Flow
|
-4.67 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
